InspireMD (NSPR) Fundamental Analysis: Revenue, Earnings & Valuation

1.48 / 10

Underperform

Fundamental evaluation presents poor characteristics (1.5/10). Strengths encompass Revenue-MV, but headwinds are noted in Profit-MV and Net income-Revenue. This justifies prudent view.

Analysis Checks(1/10)

Revenue-MV

Value-1.31

Score2/3

Weight5.33%

1M Return-1.62%

ROA (%)

Value-83.96

Score0/3

Weight14.79%

1M Return-6.45%

ROE (diluted) (YoY growth rate %)

Value-76.27

Score0/3

Weight15.10%

1M Return-5.73%

Profit-MV

Value0.62

Score1/3

Weight1.50%

1M Return-0.42%

Net income-Revenue

Value-0.05

Score1/3

Weight9.57%

1M Return-3.05%

Fixed assets turnover ratio

Value1.62

Score1/3

Weight4.49%

1M Return-1.32%

Annualized net profit margin on total assets (%)

Value-83.96

Score0/3

Weight14.79%

1M Return-6.45%

Asset-MV

Value-0.72

Score1/3

Weight13.24%

1M Return-4.53%

Cash-MV

Value0.01

Score1/3

Weight14.30%

1M Return-5.10%

Net profit / Total profit (%)

Value100.13

Score1/3

Weight6.90%

1M Return-2.24%

Is NSPR fundamentally strong?

NSPR scores 1.48/10 on fundamentals and holds a Premium valuation at present. Backed by its -106.88% ROE, -543.33% net margin, -1.24 P/E ratio, 1.09 P/B ratio, and 0.00% earnings growth, these metrics solidify its Underperform investment rating.